Diabetes and Organ Dysfunction in the Developing and Developed World

Authors

  • Ian James Martins

Keywords:

global, diabetes, appetite, nafld, neurodege -neration, nutrition, obesity, metabolic syndrome, pancreatic disease

Abstract

Induction of global organ disease has become important with the events related to diabetes in both the developed and developing world. Type 2 diabetes and peripheral organ disease are connected to Type 3 diabetes that involves the brain early in life associated with brain diseases (stroke, dementia, Alzheimer's disease).The incidence of diabetes has been predicted to increase to 21% by 2050. In various continents the rise in the global diabetes epidemic has been associated with diseases of various organ diseases related to obesity, diabetes and neurodegenerative diseases (Parkinson's disease and Alzheimer's disease). Nutritional therapy has become of central importance as early nutritional therapy may delay organ disease and aging. Environmental factors such as stress, diet and lifestyle are important to consider with the global increase in chronic diseases that alter neuroendocrine responses that cause appetite dysregulation that are closely linked to reduced lifespan relevant to pancreatic disease, NAFLD and neurodegeneration.

How to Cite

Diabetes and Organ Dysfunction in the Developing and Developed World. (2015). Global Journal of Medical Research, 15(3), 15-21. https://medicalresearchjournal.org/index.php/GJMR/article/view/

Author Biography

Ian James Martins

Nobel Scientist Award 2026, Nobel Research Award 2024 (Scientific Laurels), Life Journey and career: Video Program: Live platform: https://youtu.be/cYy4OmTkKvY?t=21, Eminent Scientist Award (INSO 2023), Excellence Service Award (INSO 2023), Outstanding Scientist Award 2022, (INSO AWARDS), International Scientist Lifetime Achievement Award 2022 (INSO AWARDS), Distinguished Scientist Award in "International Scientist Awards on Engineering, Science and Medicine", (2021), Dr Martins is now in the top 30 INTERNATIONAL FELLOWS of history (https://sites.google.com/site/internationalindexing/advisory-board). Dr Martins is a WORLD CHAMPION and has World Records to his credit in Endocrinology & Metabolism, Diabetes and Nutrition, Dr.Med, DSc (Honoris Causa) Doctrin De Science Award Honoris Causa), Top Scholar (Scholar GPS, 0.5%), AD Scientific Index Rankings for Scientist, 139201 from 1037828. Editor/Reveiwer for Open Acess Pub/MDPI and Scientific Reports (Nature) journals and other journals. Dr Martins has reveiwed approx. 6450 INVITED articles over past 8 years. Advisory Board Member for Photon Journal. Chief Editor for Biomedical and Pharmacology, Chief Editor for Journal of Neuroscience and Neurological Surgery, Chief Editor for International Journal of Diabetes Research (2014-2021), Research and Reviews: Neuroscience(2016-2021) and Journal of Diabetes and Clinical Studies (2017-2021),Advancement in Case Studies (2020-2023), American Journal of Biomedical Science and Research (2023), Global Journal of Endocrinology and Metabolism (2020-2023), Interventions in Obesity and Diabetes (2020-2023), Journal of Spine and Neuroscience, Innovations in Molecular Biotechnology, Journal of Metabolic Syndrome and Journal of Diabetes, Obesity and Metabolism, Journal of Diabetes Research and Management. BIT Member (BIT Congress. Inc) with an h-index of >302. Google Scholar (42),ResearchGate (41) with RESEARCH INTEREST SCORE in Nutrition and Dietetics (> 97 %) of all RESEARCHGATE MEMBERS > 2967, > 76600 reads, 76 mentions, 362 Recommendations. Scopus Mendeley (29), UWA Research Repository (25), Semantic Scholar (34), OpenAlex (32), Web of Science Researcher ID AAC-3215-2020 (27) Top Peer Reveiwer, 515 verified reveiws and 105 editor records. Scientist for The Science Advisory Board (USA) and an Academic with Academia.edu (>18213 veiws, >2680 citations) 0.5% CUP. Postdoctoral Researcher Frontiers in Genetics (14,463 veiws/downloads, 1527 citations),105 Editorial Contributions, Dimensions (1909 citations),AD Scientific Index Ranking (>5223 citations (h=39), Scholar GPS (33) . The citations past 25 years >40000. Editorial Board Member for 150 journals. Semantic Scholar profile with 133 highly influential citations from 204 PUBLICATIONS, ECU RESEARCH ONLINE (>13942) downloads across 52 papers). Scientific Research Publishing articles (46445 downloads, 72450 veiws, 294 citations). Winner (World Academic Championship -2017) in Diabetes and Medical Science (Nutrition). 1790 INTERNATIONAL Certificates from conferences, congresses, summits and journals. Keynote addresses at International Conference on Biomedicine and Pharmacotherapy 2018, Global Experts Meeting on Diabetes, Hypertension and Metabolic Syndrome 2018, Immunology World 2018, Laboratory Medicine 2018, Innovate Pharma 2017, Innovate Neurology 2017, World Diabetes and Endocrinology Summit-2017 and Pharmacology and Ethnopharmacology 2016. Chair Sessions on International Conference on Biomedicine and Pharmacotherapy 2018, Global Experts Meeting on Diabetes, Hypertension and Metabolic Syndrome 2018, Laboratory management, Cytogenetics, Clinical Microbiology, Diagnostic Laboratory Medicine, 13th Interantional Conference on Laboratory Medicine and Pathology, Berlin, Germany, June 25-26, 2018, Chairing Sessions on Vaccinology, Immunopathology, Immunotherapy, Immune Proteomics, Cancer and Tumour Oncology, 7th World Congress on Immunology, Amsterdam, Netherlands, April 19-20, 2018, Chair, Biotherapeutics for Diseases, Bit's 2nd International Congress of Biotherapy-2018 (Committee Member), Chair, Innovate Conferences 2017, Chair/Co-Chair at congress World Gene Convention-2016 (Shanghai, China, Pharmacology and Ethanopharmacology 2016 (Chicago, USA), Annual World Congress of Diabetes-2014 (Haikou, China), World Gene Convention-2014 (Haikou, China). Reveiwer/Editor 200 journals. > 700 IMPORTANT PUBLICATION ACHIEVEMENTS TWEET:Twitter https://twitter.com/IanJamesMartin2. Invited Organizing committee member for 200 conferences around the world (2020-2024) BLOOD TEST critical to COVID-19, diabetes and neurodegenerative disease. Sirtuin 1, a Diagnostic Protein Marker and its Relevance to Chronic Disease and Therapeutic Drug Interventions. ECPT 6.4 (2018): 209-215. The Scientific News, Advances in Treating Diseases. November Edition, 2018. Annie B. Coulter

References

I. Martins (2014) The Global Obesity Epidemic is Related to Stroke, Dementia and Alzheimer's disease. 1(2), 1010.

Dirk Sander, Kerstin Sander, Holger Poppert (2008) Review: Stroke in type 2 diabetes. 8(5), 222-229. https://doi.org/10.1177/1474651408096677

Ian Martins, Wei Lim, Andrea Wilson, Simon Laws, Ralph Martins (2013) The acceleration of aging and Alzheimer's disease through the biological mechanisms behind obesity and type II diabetes. 5(05), 913-920. https://doi.org/10.4236/health.2013.55121

I. Martins (2013) Increased Risk for Obesity and Diabetes with Neurodegeneration in Developing Countries. s1(01), 1.

Martins I.J, Wilson A.C, Lim W.L.F, Laws S.M, et Laws S.M (2012) Sirtuin 1 mediates the obesity induced risk of common degenerative diseases: Alzheimer's disease, coronary artery disease and type 2 diabetes. 4(12), 1448-1456. https://doi.org/10.4236/health.2012.412a209

Monte De la, J. Wands (2008) Alzheimer's disease is Type 3 diabetes- Evidence Reviewed. 2(5), 1101-1113.

I. Martins (2014) Nutritional and Genotoxic Stress Contributes to Diabetes and Neurodegenerative Diseases such as Parkinson's and Alzheimer's Diseases. 3.

Yoshino J, Klein S (2013) A Novel Link Between Circadian Clocks and Adipose Tissue Energy Metabolism. 62(7), 2175-2177.

Creegan Martins IJ, Lim W.L.F, Martins R.N (2013) Molecular insights into appetite control and neuroendocrine disease as risk factors for chronic diseases in Western countries. 3, 11-33.

Ian Martins, Rhona Creegan (2014) Links between Insulin Resistance, Lipoprotein Metabolism and Amyloidosis in Alzheimer's Disease. 06(12), 1549-1579. https://doi.org/10.4236/health.2014.612190

Ian Martins (2014) Induction of NAFLD with Increased Risk of Obesity and Chronic Diseases in Developed Countries. 04(04), 90-110. https://doi.org/10.4236/ojemd.2014.44012

Laedtke Janson J, O'Brien Parisi J.E, Petersen R.C, Butler P.C (2004) Increased Risk of Type 2 Diabetes in Alzheimer Disease. 53(2), 474-481.

H. Liang, Y. Zhong, S. Zhou, Q. Li (2011) Palmitic acid-induced apoptosis in pancreatic β-cells is increased by liver X receptor agonist and attenuated by eicosapentaenoate. 25(5), 711-8.

Maedler K, Dyntar Spinas G.A, Kaiser Moritz W, et al (2001) Distinct Effects of Saturated and Monounsaturated Fatty Acids on β-Cell Turnover and Function. 50(1), 69-76. https://doi.org/10.2337/diabetes.50.1.69

Wang C, Guan Y, Yang J (2010) Cytokines in the Progression of Pancreatic β-Cell Dysfunction International Journal of Endocrinology;Volume. 2010, 1-10.

Louis Feurino, William Fisher, Uddalak Bharadwaj, Qizhi Yao, Changyi Chen, Min Li (2006) Current Update of Cytokines in Pancreatic Cancer: Pathogenic Mechanisms, Clinical Indication, and Therapeutic Values. 24(7), 696-703. https://doi.org/10.1080/07357900600981398

Alonso-Magdalena Ropero A.B, Ripoll García-García E, et Fuentes E (2008) Bisphenol‐A disruption of the endocrine pancreas and blood glucose homeostasis. 31(2), 194-200. https://doi.org/10.1111/j.1365-2605.2007.00832.x

Chi Yang J, Guan Burkhardt B.R, Wolf B.A (2010) Leucine metabolism in regulation of insulin secretion from pancreatic beta cells. 68(5), 270-279.

Brouwer A.E, Carroll P.B, Atwater I.J (1991) Effects of Leucine on Insulin Secretion and Beta Cell Membrane Potential in Mouse Islets of Langerhans. 6(2), 221-228.

Zawalich W.S, Zawalich K.C (1997) Influence of pyruvic acid methyl ester on rat pancreatic islets, Effects on insulin secretion, phosphoinositide hydrolysis, and sensitization of the beta cell.J. Biol. 272(6), 3527-3531.

Michael MacDonald (1995) Feasibility of a mitochondrial pyruvate malate shuttle in pancreatic islets. Further implication of cytosolic NADPH in insulin secretion. J Biol. 271(9), 5287a. https://doi.org/10.1016/s0021-9258(18)82583-2

Bakowski D, Parekh A.B (2007) Regulation of Store-Operated Calcium Channels by the Intermediary Metabolite Pyruvic Acid. 17(12), 1076-1081.

Xiaocun Sun, Michael Zemel (2007) Leucine and Calcium Regulate Fat Metabolism and Energy Partitioning in Murine Adipocytes and Muscle Cells. 42(4), 297-305. https://doi.org/10.1007/s11745-007-3029-5

Dunn K.M, Nelson M.T (2010) Calcium and diabetic vascular dysfunction. Focus on "Elevated Ca2+ sparklet activity during acute hyperglycemia and diabetes in cerebral arterial smooth muscle cells". C203-C205.

Parekh A.B (2000) Calcium signaling and acute pancreatitis: Specific response to a promiscuous messenger. 97(24), 2933-1293.

Katherine Whalley (2011) Circadian rhythm: Calcium sets the tempo. 12(8), 434-435. https://doi.org/10.1038/nrn3073

I. Martins (2013) Appetite dysregulation and obesity in Western Countries.

Carl Lavie, Mandeep Mehra, Richard Milani (2005) Obesity and heart failure prognosis: paradox or reverse epidemiology?. 26(1), 5-7. https://doi.org/10.1093/eurheartj/ehi055

B. Mathew (2008) Obesity: Effects on Cardiovascular Disease and its Diagnosis. 21.

L. Guarente (2007) Sirtuins in Aging and Disease. 72.

M. Hansen, T. Connolly (2008) Nuclear receptors as drug targets in obesity, dyslipidemia and atherosclerosis. 9(3).

I. Martins (2015) Unhealthy Nutrigenomic Diets Accelerate NAFLD and Adiposity in Global communities. 15-106.

Bullen JW, Bluher S, Kelesidis T, Mantzoros CS (2007) Regulation of adiponectin and its receptors in response to development of diet-induced obesity in mice. 292, 1079-86.

Al-Attas O.S, Al-Rubeaan Al-Daghri N.M, da N.F, et Sabico S.L (2009) Changes in endotoxin levels in T2DM subjects on anti-diabetic therapies. 8(1), 20. https://doi.org/10.1186/1475-2840-8-20

Vaccaro M.I, Calvo E.L, Suburo A.M, Lanosa Sordelli D.O, et al (2000) Lipopolysaccharide directly affects pancreatic acinar cells: implications on acute pancreatitis pathophysiology. 45(5), 915-926.

Ian Martins (2015) LPS Regulates Apolipoprotein E and Aβ Interactionswith Effects on Acute Phase Proteins and Amyloidosis. 04(02), 69-77. https://doi.org/10.4236/aar.2015.42009

I. Martins, V. Gupta, A. Wilson, S. Fuller, R. Martins (2014) Interactions Between Apo E and Amyloid Beta and their Relationship to Nutriproteomics and Neurodegeneration. 11(3), 171-183.

Carol Murray, Donal Skelly, Colm Cunningham (2011) Exacerbation of CNS inflammation and neurodegeneration by systemic LPS treatment is independent of circulating IL-1β and IL-6. 8(1), 50. https://doi.org/10.1186/1742-2094-8-50

Lee, Magkos Mantzoros, C. Kang, E. (2011) Effects of leptin and adiponectin on pancreatic β-cell function. 60(12), 1664-1672.

Wang L., Li L., Ran X., Long M., Zhang M. (2013) Lipopolysaccharides reduce adipogenesis in 3T3-L1 adipocytes through activation of NF-κB pathway and downregulation of AMPK expression. 13(4), 338-46.

Kadiri Vatier C, Chapron Muscat A, et Capeau J (2012) Visceral and subcutaneous adipose tissue from lean women respond differently to lipopolysaccharide-induced alteration of inflammation and glyceroneogenesis Nutrition and Diabetes. 2(12), e51-e51. https://doi.org/10.1038/nutd.2012.29

Feng Wang, Margery Herrington, Jörgen Larsson, Johan Permert (2003) The relationship between diabetes and pancreatic cancer. 2(1), 4. https://doi.org/10.1186/1476-4598-2-4

Morrison M (2012) Pancreatic Cancer and Diabetes. 771, 229-239.

Machann Heni M, Staiger H, Peter Schwenzer N.F, et al (2010) Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fasting glucose and/or impaired glucose tolerance: a nuclear magnetic resonance study.

S. Collins, C. Londos, D. Gauguier, A. Clark (2008) Pancreatic ectopic fat is characterized by adipocyte infiltration and altered lipid composition. 26(3), 522.

Shi-Ping Ding, J. Li, Jin (2003) A mouse model of severe acute pancreatitis induced with caerulein and lipopolysaccharide. 9(3), 584. https://doi.org/10.3748/wjg.v9.i3.584

Nakamura Shimizu K, Ayabe K, T, T. Taira (2015) Bacterial cell wall components regulate adipokine secretion from visceral adipocytes. 9(3), 584-589.

S. Obara, Ariyoshi Akifusa S, Usui Okinaga T (2014) Pyroglutamated Apelin-13 Inhibits Lipopolysaccharide-Induced Production of Pro-Inflammatory Cytokines in Murine Macrophage J774.1 Cells. 03(02), 59-66. https://doi.org/10.4236/mri.2014.32007

Hashimoto Kubota N, et Eto K (2008) Adiponectin induces insulin secretion in vitro and in vivo at a low glucose concentration. 51(5), 59-66.

Diabetes and Organ Dysfunction in the Developing and Developed World

Published

2015-01-30

How to Cite

Diabetes and Organ Dysfunction in the Developing and Developed World. (2015). Global Journal of Medical Research, 15(3), 15-21. https://medicalresearchjournal.org/index.php/GJMR/article/view/